Lanthanum carbonate, Sevelamer
INDICATION
- Hyperphosphataemia in patients with chronic renal failure.
NEMLC RECOMMENDATION
- Approved
Special Access.- Special Access may be granted on recommendation by the PTC.
REVIEW INDICATORS
- Evidence that the use of non-calcium-based phosphate binders significantly reduces all-cause or cardiovascular mortality and/or cardiovascular comorbidities in patients with ESRD.
- Reduction in cost of sevelamer through price reduction or the introduction of generic equivalents
DATE RATIFIED